Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
Cigna Corp(CI)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for CI
09/16/2026: CI (1-star) is currently NOT-A-BUY. Pass it for now.
Cigna Corp is a diversified global health services company that operates through its two primary platforms, Evernorth Health Services and Cigna Healthcare. The company has a leading position in the pharmacy benefit management market, which creates a competitive moat by integrating pharmacy data with clinical care. While Cigna benefits from stable, recurring revenue in the employer-sponsored insurance market, it faces significant risks from regulatory scrutiny over drug pricing and potential changes to healthcare policy. Cigna stock is often considered a solid choice for value-oriented and dividend-focused investors. Looking forward, investors should monitor the company's ability to navigate healthcare cost inflation and potential regulatory shifts affecting its PBM segment.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | Cigna offers steady growth via its PBM business but operates in a mature, highly regulated industry. |
| Momentum investor | Strong fit while signal remains positive | The stock often follows strong trends based on sector-wide positive regulatory news or earnings beats. |
| Value investor | Strong fit | Cigna often trades at a moderate P/E multiple compared to broader market indices, offering value relative to earnings. |
| Dividend investor | Strong fit | The company provides a reliable dividend and has a commitment to consistent capital return. |
| Low-risk investor | Mixed fit | While established, the company faces significant regulatory and political headline risk that can increase volatility. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium | Healthcare stocks are sensitive to political cycles and election-year rhetoric. |
| Valuation risk | Low | The stock typically trades at reasonable valuation multiples, limiting extreme downside from multiple compression. |
| Competition risk (PBM/Insurance) | High | Intense competition from UNH and CVS forces constant pressure on pricing and margins. |
| Business quality | Strong | Cigna possesses a sticky, high-moat business model due to its integrated health and pharmacy services. |
| Dividend income | Medium | Dividends are secure, though the yield may not be as high as pure-play utility or income stocks. |
| Execution risk | Medium | Continued success depends on the ability to manage medical costs effectively across a diverse member base. |
Price Behavior
Steady Uptrend
The stock demonstrates consistent and steady upward price momentum.
Smooth
The stock has moved along a generally orderly path with only modest fluctuations.
Analysis of Past Performance
Type Stock | Historic Profit -43.94% | Avg. Invested days 30 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/16/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 76.34B USD | Price to earnings Ratio 11.94 | 1Y Target Price 339.36 |
Price to earnings Ratio 11.94 | 1Y Target Price 339.36 | ||
Volume (30-day avg) 1.6M shares | Beta 0.32 | 52 Weeks Range 234.17 - 308.44 | Updated Date 09/16/2026 |
52 Weeks Range 234.17 - 308.44 | Updated Date 09/16/2026 | ||
Dividends yield (FY) 2.12% | Basic EPS (TTM) 24.19 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Evernorth Health Services | Pharmacy benefit management, specialty pharmacy, and care delivery. | This is the 'engine room' that processes drug claims and provides specialty medicine, acting as a major growth driver. |
| Cigna Healthcare | Medical, dental, and supplemental insurance plans. | This is the core insurance business that collects premiums and manages risks for employer and individual clients. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE 11.94 | Forward PE 8.68 | Enterprise Value 101.35B | Price to Sales(TTM) 0.27 |
Enterprise Value 101.35B | Price to Sales(TTM) 0.27 | ||
Enterprise Value to Revenue 0.36 | Enterprise Value to EBITDA 7.93 | Shares Outstanding 264.24M | Shares Floating 262.92M |
Shares Outstanding 264.24M | Shares Floating 262.92M | ||
Percent Insiders 1.44 | Percent Institutions 92.18 |
Upturn AI Summary
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
About Cigna Corp
Exchange NYSE | Headquarters Bloomfield, CT, United States | ||
IPO Launch date 1982-03-31 | President, CEO & Director Mr. Brian Case Evanko C.F.A. | ||
Sector Healthcare | Industry Healthcare Plans | Full time employees 65669 | Website https://www.thecignagroup.com |
Full time employees 65669 | Website https://www.thecignagroup.com | ||
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.